Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCSNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CR.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KB.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CJ.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XANNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EU.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.28 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.272NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.371NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.353NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.407NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.182NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.1.218NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
XBB.1.12.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.22 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.128NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.405NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.296NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.412NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.421NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.364NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.82NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.251NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.144NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.288NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used